LOS ANGELES, July 11, 2025 (GLOBE NEWSWIRE) — ServiceTitan (Nasdaq: TTAN), the software platform that powers the trades, today announced that it will host an investor session at Pantheon 2025, the Company’s annual user conference in Anaheim, CA. The in-person investor session will be held on Thursday, September 18, 2025. ServiceTitan Pantheon 2025 Investor SessionWhen: Thursday, September 18, 2025Where: Anaheim Marriott and Anaheim Convention CenterTime: 8:00am to 1:00pm Pacific Time (PT) Event details and registration details here for qualified investors and analysts. Formal investor agenda to follow. A live webcast will be hosted on https://investors.servicetitan.com, where a replay will also be available for twelve months. About ServiceTitanServiceTitan (Nasdaq: TTAN) is the software platform that powers trades businesses. The...

Tel Aviv, Israel, July 11, 2025 (GLOBE NEWSWIRE) — Viewbix Inc. (Nasdaq: VBIX) (“Viewbix” or the “Company”), a global developer of ad-tech innovative technologies, today announced that it has entered into definitive agreements with certain strategic institutional investors for the purchase and sale of approximately $4.5 million shares of the Company’s common stock and pre-funded warrants. The entire transaction has been priced at-the-market under Nasdaq rules. Following the transaction, the Company plans to continue its previously announced process to identify and explore potential new business opportunities, investments and activities in a variety of new sectors. In connection with the offering, the Company will issue an aggregate of 925,923 units and pre-funded units. The common units will be sold at a price of $4.86 per unit;...

Eimskip has reached an agreement to sell the vessel Lagarfoss. Lagarfoss was built in 2014 in China and was specifically designed for Eimskip’s shipping routes. The vessel has served the Company for over a decade and played a key role in its operations. Since the book value of the vessel exceeds the sale price, Eimskip will record a loss of sale of approximately EUR 3.4 million in the third quarter of 2025. The buyer of Lagarfoss is company Grupo Sousa, which is located in Madeira Portugal. The company is the owner of the shipping company GS Lines. GS Lines operates six vessels that provides regular service between mainland Portugal, the Azores, Madeira, Canry Islands, Cape Verde and Guinea-Bissau. The vessel is expected to be delivered to a new owner in Reykjavík, during the period of August to September. The sale is subject to standard...

A Collaboration of Boston Icons That Hits It Out of The ParkSamuel Adams and Boston Red Sox Extend Official Partnership Through 2035From the Sam Deck to Sammy’s on Third, the partnership between Samuel Adams and the Boston Red Sox continues to bring a true taste of Boston to every game-day moment. Photo by Maddie Malhorta/Boston Red Sox/Getty Images.Boston, MA, July 11, 2025 (GLOBE NEWSWIRE) — Samuel Adams, the #1 brand known for offering variety and seasonality[1], has renewed its multiyear partnership with the Boston Red Sox, remaining the team’s Official Beer for the next decade. This partnership with Boston Beer Company’s flagship brand has been a fan favorite since 2018, when Sam Adams became the first American craft brewer to enter a partnership with a big-league franchise for this length of time and at this level....

NEW YORK, July 11, 2025 (GLOBE NEWSWIRE) — eToro Group Ltd. (“eToro”, or the “Company”) (NASDAQ: ETOR), the trading and investing platform, announced today it will release second quarter 2025 financial results before the market opens on Tuesday, August 12, 2025, with a webcast to follow at 8:30 AM ET / 5:30 AM PT. The webcast and related materials will be available at investors.etoro.com. Publishing research analysts will be provided an opportunity to ask company management live questions during the webcast. Following the webcast, a replay and transcript will be available at investors.etoro.com. Prior to the webcast, eToro shareholders can submit and upvote questions through the following link: https://forms.gle/xjwhWD3uLWSJFs257 until Thursday, July 31, 2025, at 5:00 PM ET / 2:00 PM PT. During the webcast, management will address...

According to industry sources, “Ready to Build” battery storage projects of this capacity may yield up to $13.5 million Neve Yarak, Israel, July 11, 2025 (GLOBE NEWSWIRE) — Today, N2OFF, Inc.(NASDAQ: NITO) (FSE:80W) (“N2OFF” and the “Company”), a cleantech company investing in “Agrifood” Techs Solutions and sustainable energy solutions through Solar Energy assets based on the RTB (Ready to Build ) business model, announced completion of the second installment of a $2.7 million investment for financing and supporting the development of two Battery Energy Storage Systems (“BESS”) in Sicily, Italy, each with a capacity of 98MWp/392MWh. To date, the Company has invested over $1.2 million in its 70% -owned Italian subsidiary. The Company’s BESS projects in Italy are RTB assets, aiming to secure the necessary permits, grid...

CHENNAI, India, July 11, 2025 (GLOBE NEWSWIRE) — Sify Technologies Limited (NASDAQ: SIFY), India’s leading Digital ICT solutions provider with global service capabilities spanning Data Center, Cloud, Networks, Security and Digital services, today announced that it will report its unaudited IFRS financial results for the First quarter ended June 30, 2025 on Friday, July 18, 2025 before the market opens.  In conjunction with the announcement, Sify will host a conference call at 8:30 AM ET with Mr. Raju Vegesna, Chairman of the Board and Mr. M P Vijay Kumar, Executive Director & Group CFO. Interested parties may participate by dialling +1-888-506-0062 (Toll Free in the U.S. or Canada) or +1-973-528-0011 (International), which will also be simultaneously broadcast live over the Internet at www.sifytechnologies.com/investors or...

TORONTO, July 11, 2025 (GLOBE NEWSWIRE) — Rogers Communications, Inc. (“Rogers” or the “Company”) (TSX: RCI.A and RCI.B; NYSE: RCI) today announced the commencement of separate offers (the “Offers”) to purchase for cash any and all of the outstanding notes of each series listed in the table below (collectively, the “Notes”), up to a maximum of US$1,250,000,000 aggregate Total Consideration (as defined below). Subject to the Consideration Cap Condition (as defined below), the series of Notes that are purchased in the Offers will be based on the acceptance priority levels (each, an “Acceptance Priority Level”) set forth in the table below. If a given series of Notes is accepted for purchase pursuant to the Offers, all Notes of that series that are validly tendered and not validly withdrawn will be accepted for purchase. No series...

TORONTO, July 11, 2025 (GLOBE NEWSWIRE) — Rogers Communications Inc. (“Rogers” or the “Company”) (TSX: RCI.A and RCI.B; NYSE: RCI) today announced the commencement of separate offers (the “Offers”) to purchase for cash up to C$400,000,000 (the “Maximum Purchase Amount”) in aggregate purchase price, excluding accrued and unpaid interest, of its outstanding senior notes of each series listed in the table below (collectively, the “Notes”), which Maximum Purchase Amount may be increased, decreased or waived by the Company in its sole discretion. Each Offer is subject to the satisfaction or waiver of certain conditions. The Offers The Offers are made upon the terms and subject to the conditions set forth in the offer to purchase dated July 11, 2025 relating to the Notes (the “Offer to Purchase”). Capitalized terms used but not defined...

Median Overall Survival (OS) of 13.9 months in triple negative breast cancer (TNBC) exceeds Trodelvy (11.8 months) and doubles control (6.9 months) OS of 17.3 months in HR+ metastatic breast cancer surpasses Trodelvy (14.4 months) and control (11.2 months) No treatment related discontinuations reportedPHILADELPHIA and VANCOUVER, British Columbia, July 11, 2025 (GLOBE NEWSWIRE) — BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ) (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, today announced updated Phase 2 survival data for its lead immunotherapy candidate, Bria-IMT, in combination with an immune check point inhibitor (CPI). The data show a meaningful survival advantage in heavily pretreated metastatic breast cancer (MBC) patient...